The Power of Pills

Part 1: Pharmaceutical Industry, Profits and Obligations


1. The Pharmaceutical Industry and the Pursuit of Profits by Joel Lexchin


2. Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing Policies: 'Setting Priorities: Pharmaceuticals as Private Organizations and the Duty to Make Money/Maximize Profits' by Kristina M. Lybecker


3. The Pharmaceutical Industry and its Obligations in the Developing World by Ann Mills, Patricia Werhane, and Michael Gorman


4. Drug Companies as Organizational Hybrids by Warren Kaplan


5. Physicians and the Pharmaceutical Industry: A Symbiotic Relationship? by Ian E Marshall


6. Industry Perspectives on Equity, Access and Corporate Social Responsibility: A View from the Inside by Robert A Freeman


Part 2: Justice - Medicines as Global Public Goods


1. Pharmaceuticals, Public Health and the Law: A Public Health Perspective by W.E. Parmet


2. Access to Medications and Global Justice by David. Resnik


3. Pharmacogenetics and Global (In)Justice by Soren Holm


Part 3: The Social, Ethical and Political Challenge: Neglected Diseases


1. The Enduring Crisis in Neglected Diseases by Nathan Ford


2. Moving Beyond Charity for R&D for Neglected Diseases by J. Orbinski and B. Burciul


3. Neglected Disease Research: Health Needs and New Models for R&D by Aidan Hollis


4. Advance Purchase Commitments: Moral and Practical Problems by Donald W. Light


5. Harnessing the Power of Pharmaceutical Innovation by Thomas Pogge


Part 4: Patents and Access to Medicines


1. Patents, Profits, and the Price of Pills: Implications for Access and Availability by Michael J Selgelid and Eline M. Sepers


2. Fair Followers Expanding Access to Generic Pharmaceuticals for Low-Income Populations by Kevin Outterson


3. Abolishing the Product Patent: A Step Forward for Global Access to Drugs by Adam Mannan and Alan Story


4. Trading Health for Profit: Bilateral and Regional Free Trade Agreements Affecting Domestic Intellectual Property Rules on Pharmaceuticals by Lisa Forman


Part 5: Research Ethics a


1. Human Genomic Research Ethics: Changing the Rules by Steven H. Miles


2. Assumptions in the Standard of Care Debate by Florencia Luna


Part 6: Political Activism and Treatment Access


1. Medicines for All? Commitment and Compromise in the Fight for


Canada's Law on Compulsory Licensing for Export by Richard Elliot


2. Placing Access to Essential Medicine on the Human Rights Agenda by Brook K. Baker


Part 7: National Responsibilities


1. Producing Affordable Medicines in South Africa by Joao L. Carapinha


2. National Responsibility in the Provision of Basic Medicine by Kinsley Wilson, Laura Esmail and Jillian Clare Cohen


3. Pharmaceutical Cost-Effectiveness Pricing: Developing and Protecting a Global Ideal Form by Thomas A. Faunce


Index